Derek M. Low, MD

Professional Background

Dr Low graduated from medical school at the University of Kansas School of Medicine in 2014. He completed his internal medicine residency at the Medical University of South Carolina in Charleston, SC. Following residency he completed a combined pulmonary and critical care fellowship at the University of Colorado and National Jewish Hospital. After his clinical fellowship, he completed a 1 year research fellowship at National Jewish Hospital predominantly focusing on nontuberculous mycobacteria infection in cystic fibrosis. At the University of Kansas Hospital, Dr. Low sees patients in general pulmonary clinic as well as attending in the medical intensive care unit.

• BS, Biochemistry, Kansas State University
• MD, Medicine, University of Kansas School of Medicine
• Internship, Internal Medicine, Medical University of South Carolina
• Residency, Internal Medicine, Medical University of South Carolina
• Clinical Fellowship, Pulmonary/Critical Care Medicine, University of Colorado/National Jewish Health

• American College of Chest Physicians , Member, 2023 - Present
• American Thoracic Society, Member, 2017 - Present

---

• Low, Derek., Matthew, Wilson, Dulaney, Flume, Patrick. 2020. Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers. Journal of Cystic Fibrosis
• Low, Derek, Simpson, Kit, Rissmiller, Richard, James, Ennis. 2019. A new side of sarcoidosis: medication and hospitalization use in a privately insured patient population. Sarcoidosis Vasculitis and Diffuse Lung Diseases
• Mermis, Joel, Strom, Jeremy, Greenwood, John, Low, Derek, He, Jianghua , Stites, Steven , Simpson, Steven. 2014. Quality Improvement Initiative to Reduce Deep Vein Thrombosis Associated with Peripherally Inserted Central Catheters in Adults with Cystic Fibrosis. Annals of the Americal Thoracic Society
• Burr, Diana, Molina, Samuel, Banarjee, Debarshi, Takemoto, Dolores. 2011. Treatment with connexin 46 siRNA suppresses the growth of human Y79 retinoblastoma cell xenografts in vivo. Experimental Eye Research